Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Federal Trade Commission
Citi
Harvard Business School
Cipla
Mallinckrodt
Daiichi Sankyo
Johnson and Johnson
McKinsey

Generated: November 12, 2018

DrugPatentWatch Database Preview

Apotex Inc Company Profile

« Back to Dashboard

What is the competitive landscape for APOTEX INC, and what generic and branded alternatives to APOTEX INC drugs are available?

APOTEX INC has two hundred and thirty-five approved drugs.

There are sixteen tentative approvals on APOTEX INC drugs.

Drugs and US Patents for Apotex Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc DILTZAC diltiazem hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 076395-001 Feb 1, 2006 AB4 RX No No ➤ Sign Up ➤ Sign Up
Apotex Inc OLANZAPINE olanzapine TABLET;ORAL 090798-006 Apr 23, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Apotex Inc QUINAPRIL HYDROCHLORIDE quinapril hydrochloride TABLET;ORAL 076240-001 Jan 26, 2006 DISCN No No ➤ Sign Up ➤ Sign Up
Apotex Inc QUETIAPINE FUMARATE quetiapine fumarate TABLET;ORAL 090960-005 Mar 27, 2012 AB RX No No ➤ Sign Up ➤ Sign Up
Apotex Inc GABAPENTIN gabapentin CAPSULE;ORAL 075360-002 Apr 6, 2005 AB RX No No ➤ Sign Up ➤ Sign Up
Apotex Inc CANDESARTAN CILEXETIL candesartan cilexetil TABLET;ORAL 202079-003 Jan 10, 2014 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Citi
Merck
Cantor Fitzgerald
Cerilliant
Medtronic
Harvard Business School
Fuji
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.